Brief: Phio Pharmaceuticals Posts FY Loss Of $10.10 Per Share
22/03/2023 21:09
March 22 (Reuters) - Phio Pharmaceuticals Corp PHIO.O :
* PHIO PHARMACEUTICALS REPORTS 2022 YEAR END FINANCIAL
RESULTS AND
PROVIDES BUSINESS UPDATE
* PHIO PHARMACEUTICALS CORP FY LOSS PER SHARE $10.10
* PHIO PHARMACEUTICALS CORP - AT DECEMBER 31, 2022, COMPANY
HAD
CASH OF $11.8 MILLION
* PHIO PHARMACEUTICALS CORP - COMPANY EXPECTS ITS CURRENT
CASH
WILL BE SUFFICIENT TO FUND CURRENTLY PLANNED OPERATIONS THROUGH
Q4 OF 2023
Source text for Eikon: ID:nPn2mScVRa
Further company coverage: PHIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing